NM_002253.4:c.3445C>G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002253.4(KDR):āc.3445C>Gā(p.Gln1149Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000133 in 1,614,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Consequence
NM_002253.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KDR | ENST00000263923.5 | c.3445C>G | p.Gln1149Glu | missense_variant | Exon 26 of 30 | 1 | NM_002253.4 | ENSP00000263923.4 | ||
KDR | ENST00000647068.1 | n.3458C>G | non_coding_transcript_exon_variant | Exon 26 of 30 | ||||||
ENSG00000250646 | ENST00000511222.1 | n.234-3380G>C | intron_variant | Intron 3 of 3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000796 AC: 20AN: 251238Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135792
GnomAD4 exome AF: 0.000135 AC: 198AN: 1461820Hom.: 0 Cov.: 31 AF XY: 0.000124 AC XY: 90AN XY: 727218
GnomAD4 genome AF: 0.000105 AC: 16AN: 152212Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74358
ClinVar
Submissions by phenotype
not provided Uncertain:1
The KDR p.Gln1149Glu variant was not identified in the literature nor was it identified in ClinVar or Cosmic. The variant was identified in dbSNP (ID: rs376432705) and LOVD 3.0. The variant was identified in control databases in 21 of 282644 chromosomes at a frequency of 0.000074 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following population: European (non-Finnish) in 21 of 129016 chromosomes (freq: 0.000163); it was not observed in the African, Latino, Ashkenazi Jewish, East Asian, European (Finnish), Other, and South Asian populations. The p.Gln1149 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and 3 of 4 in silico or computational prediction software programs (SpliceSiteFinder, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at